KYTHERA Biopharmaceuticals to Release First Quarter 2013 Operating Results

        Print
| Source: KYTHERA Biopharmaceuticals, Inc.

LOS ANGELES, May 2, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its first quarter 2013 operating results and will host an investor call and webcast at 1:30 p.m. PDT on Monday, May 13, 2013.

Individuals interested in participating in the call should dial (877) 344-3890 (U.S. and Canada) or (760) 666-3770 (international) using conference ID number 64897672. To access the webcast, please visit the Investors section of KYTHERA's website at www.kytherabiopharma.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The call will be available for replay via telephone starting May 13, 2013 at approximately 4:30 p.m. PDT, running through 11:59 p.m. PDT on May 19, 2013. To listen to the replay, dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international) using conference ID number 64897672. The archived webcast will be available on KYTHERA's website for 14 days beginning approximately one hour after the call has completed.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is a potential first-in-class, injectable treatment currently in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.  Find more information at http://www.kytherabiopharma.com.

Heather Rowe
Associate Director, Investor Relations
Tel: (818) 587-4559